Antonijevic, M.; Charou, D.; Davis, A.; Curel, T.; Valcarcel, M.; Ramos, I.; Villacé, P.; Claeysen, S.; Dallemagne, P.; Gravanis, A.;
et al. Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents. Molecules 2024, 29, 515.
https://doi.org/10.3390/molecules29020515
AMA Style
Antonijevic M, Charou D, Davis A, Curel T, Valcarcel M, Ramos I, Villacé P, Claeysen S, Dallemagne P, Gravanis A,
et al. Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents. Molecules. 2024; 29(2):515.
https://doi.org/10.3390/molecules29020515
Chicago/Turabian Style
Antonijevic, Mirjana, Despoina Charou, Audrey Davis, Thomas Curel, Maria Valcarcel, Isbaal Ramos, Patricia Villacé, Sylvie Claeysen, Patrick Dallemagne, Achille Gravanis,
and et al. 2024. "Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents" Molecules 29, no. 2: 515.
https://doi.org/10.3390/molecules29020515
APA Style
Antonijevic, M., Charou, D., Davis, A., Curel, T., Valcarcel, M., Ramos, I., Villacé, P., Claeysen, S., Dallemagne, P., Gravanis, A., Charalampopoulos, I., & Rochais, C.
(2024). Development of Pleiotropic TrkB and 5-HT4 Receptor Ligands as Neuroprotective Agents. Molecules, 29(2), 515.
https://doi.org/10.3390/molecules29020515